Clinical trial
Bioimpedance Spectroscopy (BIS): Analysis of Changes in Fluid Status in Hemodialysis Patients
NCT07803029 is registered in ClinicalTrials.gov with Per Ivarsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioimpedance Spectroscopy (BIS): Analysis of Changes in Fluid Status in Hemodialysis Patients
- Lead sponsor
- Per Ivarsen
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 11, 2025
- Completion date
- December 31, 2026
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodialysis